Search

Author/Creator Forci, B.

1. Clinical activity after fingolimod cessation: disease reactivation or rebound?. (10th July 2018)

Authors:
Frau, J.; Sormani, M. P.; Signori, A.; Realmuto, S.; Baroncini, D.; Annovazzi, P.; Signoriello, E.; Maniscalco, G. T.; La Gioia, S.; Cordioli, C.; Frigeni, B.; Rasia, S.; Fenu, G.; Grasso, R.; Sartori, A.; Lanzillo, R.; Stromillo, M. L.; Rossi, S.; Forci, B.; Cocco, E.
Journal:
European journal of neurology
Issue:
Volume 25:Number 10(2018)
Page Start:
1270
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of autologous hematopoietic stem‐cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis. (14th December 2018)

Authors:
Mariottini, A.; Innocenti, C.; Forci, B.; Magnani, E.; Mechi, C.; Barilaro, A.; Nistri, R.; Fani, A.; Saccardi, R.; Massacesi, L.; Repice, A. M.
Journal:
European journal of neurology
Issue:
Volume 26:Number 4(2019)
Page Start:
624
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search